About US
Contact us
-
FDA approves Pfizer's Prefilled Dual-Chamber Syringe for XYNTHA administration in hemophilia A patientsPfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has granted approval of the use of a Prefilled Dual-Chamber Syringe for administration of XYNTHA® Antihemop2010/8/10
-
FDA accepts Salix's XIFAXAN550 sNDA for Priority ReviewSalix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the Company's efficacy supplement to the New Drug Application (ND2010/8/10
-
FDA seeks ban on Regenerative Sciences for violating cGMPThe U.S. Food and Drug Administration is seeking an injunction in federal court against Regenerative Sciences LLC, of Broomfield, Colo., citing violations of current good manufacturing practice (cGMP)2010/8/9
-
FDA confirms Advisory Committee meeting date for lorcaserin NDA reviewArena Pharmaceuticals, Inc. (Nasdaq: ARNA) and Eisai Inc. announced today that the US Food and Drug Administration (FDA) has notified the company of the confirmed scheduling of an Endocrinologic and M2010/8/9
-
BMS to join ranks of AIDS drug companies to offer price concessionsFollowing ongoing advocacy campaigns spearheaded by AIDS Healthcare Foundation (AHF) that targeted several of the largest AIDS drug companies over their pricing and rebate policies for the nation's AI2010/8/9
-
Evonik steps up its commitment to corporate responsibility (CR)CR report 2009 published CR program for the next few years presented Evonik is aligning its business portfolio to megatrends and thus making a contribution to sustainable development Essen. I2010/8/6
-
Sanofi-aventis receives FDA approval for new Taxotere Injection Concentrate formulationSanofi-aventis U.S. announced today that the U.S. Food and Drug Administration (FDA) has approved a new one-vial formulation of its chemotherapeutic agent Taxotere® (docetaxel) Injection Concentra2010/8/6
-
BASF raises prices for isophorone diamine in EuropeBASF is raising its prices for isophorone diamine (IPDA) in Europe by €200 per metric ton, or by the corresponding amount in local currency, effective immediately or as existing contracts permit.2010/8/5
-
BASF declares Force Majeure on Plastomoll® DNA, Palatinol® N, Hexamoll® DINCH and selected Palamoll®gradesLudwigshafen , Germany – July 21, 2010 – Due to a shortage of raw materials caused by an unforeseeable technical defect in its iso-Nonanol (INA) plant in Ludwigshafen, Germany, BASF SEis currently una2010/8/5
-
Victory Pharma acquires assets of MiddleBrook PharmaceuticalsVictory Pharma, Inc. ("Victory") today announced that it has completed the acquisition of substantially all of the assets of MiddleBrook Pharmaceuticals, Inc. (OTCQB: MBRKQ). Through the acquisition,2010/8/5